CJC-1295/Ipamorelin Injections Recalled Due to Sterility Concerns
Talon Compounding Pharmacy is recalling CJC-1295 and Ipamorelin injectable vials distributed across the United States because the manufacturer cannot assure sterility of the products.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The FDA classified this as a Class II recall. Lack of sterility assurance for injectable pharmaceutical products presents a serious risk of infection or other adverse health consequences to patients who receive non-sterile injections.
Plain-English summary
Vita Pharmacy, LLC dba Talon Compounding Pharmacy is recalling CJC-1295 4MG/Ipamorelin 4MG injectable vials. The recall affects 15 vials distributed throughout the United States, including Washington, D.C. and Puerto Rico.
The recall was issued because the manufacturer cannot provide assurance that the products meet sterility standards. Affected lot numbers include 05242021:73 (BUD: 08/22/2021), 08032021:26 (BUD: 11/01/2021), 06022021:49 (BUD: 08/31/2021), and 08122021:97 (BUD: 11/10/2021).
Consumers or healthcare providers who have received these products should discontinue use and consult with their healthcare provider regarding the recall.
The recalled product
- Product
- CJC-1295 4MG/IPAMORELIN 4MG VIAL 4MG/4MG INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247
- Category
- Drug — Compounded Injectable
- Affected units
- 15
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (4)
- Lot: 05242021:73 BUD: 08/22/2021
- 08032021:26 BUD: 11/01/2021
- 06022021:49 BUD: 08/31/2021
- 08122021:97 BUD: 11/10/2021
Distribution
Part of a larger recall action
This product is one of 130 recalled by Vita Pharmacy, LLC dba Talon Compounding Pharmacy under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 130 products in this recall →Related recalls
Same manufacturer · Vita Pharmacy, LLC dba Talon Compounding Pharmacy
See all →- HighInjectable testosterone and dutasteride product recall for sterility assurance failure
FDA (Drugs) · 2021-11-17
- HighIC B Complex Injectable Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2021-11-17
- SevereTRI-MIX Injectable by Talon Compounding Pharmacy Recalled for Sterility Assurance
FDA (Drugs) · 2021-11-17
- SevereInjectable Steroid Combination Product Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2021-11-17
- HighTestosterone Bi-Blend Injectable Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2021-11-17
Same hazard · sterility assurance failure
See all →- HighDELFLEX Peritoneal Dialysis Solution bags recalled for sterility risk
FDA (Drugs) · 2026-05-13
- SevereTirzepatide/Cyanocobalamin Injectable Recalled Due to Sterility Assurance Failure
FDA (Drugs) · 2025-07-02
- HighOmnicell IVX Station Reconstitution Transfer Sets Recall
FDA (Devices) · 2025-04-16
- HighCompounded Fentanyl and Bupivacaine Epidural Injections Recalled for Sterility Assurance
FDA (Drugs) · 2025-04-02
- HighHYDROmorphone Injectable Recalled Due to Sterility Assurance Failure
FDA (Drugs) · 2024-04-03
Similar recalls
- SevereAssurance Infusion Recalls CJC-1295 and Ipamorelin Injections Due to Sterility Concerns
FDA (Drugs) · 2020-01-22
- SevereTalon Compounding Pharmacy Recalls Sermorelin Injections Due to Sterility Concerns
FDA (Drugs) · 2016-08-31
- SeverePromise Pharmacy Recalls Ipamorelin Injections Due to Sterility Concerns
FDA (Drugs) · 2019-02-20
- SevereFDA Recalls Ipamorelin Acetate Injectable Vials Due to Sterility Concerns
FDA (Drugs) · 2019-06-19
- SeverePromise Pharmacy Recalls Ipamorelin and Sermorelin Injections Due to Sterility Concerns
FDA (Drugs) · 2019-02-20
- HighCompounded Sermorelin/Glycine Injectable Vials Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2022-07-20